NCT03598608
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03598608
Title Study to Evaluate the Safety and Efficacy of a Combination of MK-4280 and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Merck Sharp & Dohme Corp.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | ISR | DEU | CAN | AUS

Facility Status City State Zip Country Details
Banner MD Anderson Cancer Center ( Site 0020) Gilbert Arizona 85234 United States Details
City of Hope ( Site 0001) Duarte California 91010 United States Details
Ronald Reagan UCLA Medical Center (Radiological Sciences) ( Site 0007) Los Angeles California 90095 United States Details
Pacific Cancer Care ( Site 0006) Monterey California 93940 United States Details
University of California San Francisco ( Site 0023) San Francisco California 94143 United States Details
Dana Farber Cancer Institute ( Site 0002) Boston Massachusetts 02215 United States Details
Fox Chase Cancer Center ( Site 0019) Philadelphia Pennsylvania 19111 United States Details
Texas Oncology-Austin Midtown ( Site 8002) Austin Texas 78705 United States Details
Concord Repatriation & General Hospital ( Site 0203) Concord New South Wales 2139 Australia Details
Princess Alexandra Hospital ( Site 0204) Woollongabba Queensland 4102 Australia Details
Monash Health ( Site 0201) Clayton Victoria 3168 Australia Details
St Vincent s Hospital (Melbourne) Limited ( Site 0202) Fitzroy Victoria 3065 Australia Details
BC Cancer ( Site 0107) Vancouver British Columbia V5Z 1L3 Canada Details
CancerCare Manitoba ( Site 0101) Winnipeg Manitoba R3E 0V9 Canada Details
Princess Margaret Cancer Centre ( Site 0100) Toronto Ontario M5G 2M9 Canada Details
Jewish General Hospital ( Site 0105) Montreal Quebec H3T 1E2 Canada Details
U. klinikum Koeln AOER ( Site 0326) Cologne North Rhine-Westphalia 50937 Germany Details
Universitaetsklinikum Leipzig AOeR ( Site 0327) Leipzig Saxony 4103 Germany Details
Rambam Medical Center ( Site 0382) Haifa 3109601 Israel Details
Hadassah Ein Karem Jerusalem ( Site 0383) Jerusalem 9112001 Israel Details
Chaim Sheba Medical Center. ( Site 0380) Ramat Gan 5262001 Israel Details
Sourasky Medical Center ( Site 0381) Tel Aviv 6423906 Israel Details
A.O. Universitaria Policlinico S. Orsola-Malpighi ( Site 0351) Bologna Emilia-Romagna 40138 Italy Details
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori ( Site 0354) Meldola Forli-Cesena 47014 Italy Details
Humanitas-U.O di Oncologia medica ed Ematologia ( Site 0352) Rozzano Milano 20089 Italy Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field